116 related articles for article (PubMed ID: 12870816)
1. Anti-angiogenic activity of terpestacin, a bicyclo sesterterpene from Embellisia chlamydospora.
Jung HJ; Lee HB; Kim CJ; Rho JR; Shin J; Kwon HJ
J Antibiot (Tokyo); 2003 May; 56(5):492-6. PubMed ID: 12870816
[No Abstract] [Full Text] [Related]
2. Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.
Oka M; Iimura S; Tenmyo O; Sawada Y; Sugawara M; Ohkusa N; Yamamoto H; Kawano K; Hu SL; Fukagawa Y
J Antibiot (Tokyo); 1993 Mar; 46(3):367-73. PubMed ID: 8478254
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of (-)-terpestacin via catalytic, stereoselective fragment coupling: siccanol is terpestacin, not 11-epi-terpestacin.
Chan J; Jamison TF
J Am Chem Soc; 2003 Sep; 125(38):11514-5. PubMed ID: 13129351
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
Martínez-Poveda B; Verotta L; Bombardelli E; Quesada AR; Medina MA
PLoS One; 2010 Mar; 5(3):e9558. PubMed ID: 20224821
[TBL] [Abstract][Full Text] [Related]
5. Hyperforin: more than an antidepressant bioactive compound?
Medina MA; Martínez-Poveda B; Amores-Sánchez MI; Quesada AR
Life Sci; 2006 Jun; 79(2):105-11. PubMed ID: 16438991
[TBL] [Abstract][Full Text] [Related]
6. Fusaproliferin, Terpestacin and Their Derivatives Display Variable Allelopathic Activity Against Some Ascomycetous Fungi.
Cimmino A; Sarrocco S; Masi M; Diquattro S; Evidente M; Vannacci G; Evidente A
Chem Biodivers; 2016 Nov; 13(11):1593-1600. PubMed ID: 27448697
[TBL] [Abstract][Full Text] [Related]
7. Effects of endostatin and a new drug terpestacin against human neuroblastoma xenograft and cell lines.
Park KC; Choi SH
Pediatr Surg Int; 2013 Dec; 29(12):1327-40. PubMed ID: 24072200
[TBL] [Abstract][Full Text] [Related]
8. Phytotoxic sesterterpene, 11-epiterpestacin, from Bipolaris sorokiniana NSDR-011.
Nihashi Y; Lim CH; Tanaka C; Miyagawa H; Ueno T
Biosci Biotechnol Biochem; 2002 Mar; 66(3):685-8. PubMed ID: 12005073
[TBL] [Abstract][Full Text] [Related]
9. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
Martínez-Poveda B; Quesada AR; Medina MA
Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
[TBL] [Abstract][Full Text] [Related]
10. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. IV. Preparation of fluorinated squalestatins by directed biosynthesis.
Cannell RJ; Dawson MJ; Hale RS; Hall RM; Noble D; Lynn S; Taylor NL
J Antibiot (Tokyo); 1993 Sep; 46(9):1381-9. PubMed ID: 8226317
[TBL] [Abstract][Full Text] [Related]
11. Hyperforin acts as an angiogenesis inhibitor.
Schempp CM; Kiss J; Kirkin V; Averbeck M; Simon-Haarhaus B; Kremer B; Termeer CC; Sleeman J; Simon JC
Planta Med; 2005 Nov; 71(11):999-1004. PubMed ID: 16320199
[TBL] [Abstract][Full Text] [Related]
12. Novel sulfated sesterterpene alkaloids from the marine sponge Fasciospongia sp.
Yao G; Chang LC
Org Lett; 2007 Aug; 9(16):3037-40. PubMed ID: 17602640
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis.
Hussain S; Slevin M; Matou S; Ahmed N; Choudhary MI; Ranjit R; West D; Gaffney J
Angiogenesis; 2008; 11(3):245-56. PubMed ID: 18330714
[TBL] [Abstract][Full Text] [Related]
14. The biology of ophiobolins.
Au TK; Chick WS; Leung PC
Life Sci; 2000 Jul; 67(7):733-42. PubMed ID: 10968403
[TBL] [Abstract][Full Text] [Related]
15. The squalestatins: synthesis and biological activity of some C3-modified analogues; replacement of a carboxylic acid or methyl ester with an isoelectronic heterocyclic functionality.
Bamford MJ; Chan C; Craven AP; Dymock BW; Green D; Henson RA; Kirk BE; Lester MG; Procopiou PA; Snowden MA
J Med Chem; 1995 Sep; 38(18):3502-13. PubMed ID: 7658437
[TBL] [Abstract][Full Text] [Related]
16. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. V. Minor metabolites.
Blows WM; Foster G; Lane SJ; Noble D; Piercey JE; Sidebottom PJ; Webb G
J Antibiot (Tokyo); 1994 Jul; 47(7):740-54. PubMed ID: 8071119
[TBL] [Abstract][Full Text] [Related]
17. Alteration of membrane polarization by (-)-terpestacin, a biologically active fungal metabolite.
Grigoriev PA; Schlegel B; Schmidtke M; Gräfe U
Pharmazie; 2002 Sep; 57(9):653-4. PubMed ID: 12369460
[No Abstract] [Full Text] [Related]
18. Antitubercular sesterterpenes from the Thai sponge Brachiaster sp.
Wonganuchitmeta SN; Yuenyongsawad S; Keawpradub N; Plubrukarn A
J Nat Prod; 2004 Oct; 67(10):1767-70. PubMed ID: 15497961
[TBL] [Abstract][Full Text] [Related]
19. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective synthesis of (-)-terpestacin and structural revision of siccanol using catalytic stereoselective fragment couplings and macrocyclizations.
Chan J; Jamison TF
J Am Chem Soc; 2004 Sep; 126(34):10682-91. PubMed ID: 15327327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
